BEVERLY, Massachusetts,. North Shore InnoVentures, (NSIV) one of New England’s leading technology incubators and business accelerators, announced today that six new startup companies in the cleantech and life sciences sectors have joined as members since March 2013, for a total of 21 companies now in the program. “This is a record number of companies joining […]
MADISON, WIS.,– Cellular Dynamics International, Inc., a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced that it has filed a registration statement on June 3, 2013, on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering of its common […]
ALAMEDA, Calif — BioTime, Inc. (NYSE MKT: BTX) today announced that it has agreed to sell up to an aggregate of 2,180,016 common shares and 545,004 warrants to purchase common shares, in “units” with each unit consisting of one common share and one-quarter of a warrant, at an offering price of $4.155 per unit. BioTime […]
RADNOR, PA, – VWR Funding, Inc. (the “Company”), the parent company of VWR International, LLC, a global provider of laboratory supplies, equipment and services, announced today that it intends to seek a repricing of its $242 million U.S. dollar extended term loan and its €476 million Euro extended term loan, in each case, maturing in […]
Cambridge, UK, :Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced the final closing of its Series C funding round. The latest £6.9m ($10.5m) placement for ordinary shares brings to a close a cumulative total for the round of £18.2m ($29.1m) and will enable Horizon to […]
Ghent, Belgium – – Trinean, the leading provider of microfluidic spectrophotometry platforms, announced today to have secured a 1 million euro investment in a second closing of its 3.7 million fundraising round. The investment is done by Capricorn Health-tech Fund NV (Leuven, Belgium) which is managed by Capricorn Venture Partners NV. Dr. Gaston Matthyssens, Trinean’s […]
STATESVILLE, N.C., — Kewaunee Scientific Corporation (Nasdaq: KEQU) announced today its Board of Directors declared a quarterly cash dividend of ten cents per outstanding share, payable on June 24, 2013 to stockholders of record at the close of business on June 10, 2013. Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and […]
MINNEAPOLIS– MOCON, Inc. (NASDAQ: MOCO) announced today that on May 23, 2013, its Board of Directors declared a quarterly cash dividend of eleven cents ($0.11) per share, payable on August 16, 2013, to shareholders of record on August 2, 2013. The Company has provided stockholders with quarterly dividends for the 100th consecutive quarter. Prior to […]
SANTA CLARA, Calif.– Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 12 cents per share of common stock will be paid on July 24 to all shareholders of record as of the close of business on July 2. Agilent’s board of directors approved the initiation of quarterly cash dividends to its […]
SEATTLE – NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares to be sold and the price range […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
